только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 11 / 30
Страница 1 / 3

Список литературы

  1. Maurer M. и др. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update // Allergy. 2018. Т. 73, № 8. С. 1575–1596.
  2. Caballero T. и др. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations. // J. Investig. Allergol. Clin. Immunol. 2011. Т. 21, № 6. С. 422–441.
  3. Cicardi M. и др. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group // Allergy. 2014. Т. 69, № 5. С. 602–616.
  4. Obtułowicz K. Bradykinin-mediated angioedema // Polish Arch. Intern. Med. 2016. Т. 126, № 1–2. С. 76–85.
  5. Picard C. и др. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 // J. Clin. Immunol. 2015. Т. 35, № 8. С. 696–726.
  6. Germenis A.E., Speletas M. The Genetics of Hereditary Angioedema the Iceberg Slowly Emerges // J. Angioedema. 2016. Т. 2, № 1. С. 8–17.
  7. Germenis A.E., Speletas M. Genetics of Hereditary Angioedema Revisited // Clin. Rev. Allergy Immunol. Clinical Reviews in Allergy & Immunology, 2016. Т. 51, № 2. С. 170–182.
  8. Santacroce R. и др. The Genetics of Hereditary Angioedema: A Review // J. Clin. Med. 2021. Т. 10, № 9. С. 2023.
  9. Davis A., Lu F., Mejia P. C1 inhibitor, a multi-functional serine protease inhibitor // Thromb. Haemost. 2010. Т. 104, № 11. С. 886–893.
  10. Bork K. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema // Immunotherapy. 2014. Т. 6, № 5. С. 533–551.
  11. Kaplan A.P., Joseph K. Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin- Forming Cascade // Immunol. Allergy Clin. North Am. Elsevier Inc, 2017. Т. 37, № 3. С. 513–525.
  12. Caccia S., Suffritti C., Cicardi M. Pathophysiology of Hereditary Angioedema // Pediatr. Allergy. Immunol. Pulmonol. 2014. Т. 27, № 4. С. 159–163.
  13. Bas M. и др. Nonallergic angioedema: role of bradykinin. // Allergy. 2007. Т. 62, № 8. С. 842– 856.
  14. Levi M., Cohn D.M., Zeerleder S. Hereditary angioedema: Linking complement regulation to the coagulation system // Res. Pract. Thromb. Haemost. 2019. Т. 3, № 1. С. 38–43.
  15. van Geffen M. и др. Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency // Clin. Exp. Immunol. 2012. Т. 167, № 3. С. 472–478.
  16. Cicardi M. и др. Novelties in the diagnosis and treatment of angioedema // J. Investig. Allergol. Clin. Immunol. 2016. Т. 26, № 4. С. 212–221.
  17. Bafunno V. и др. Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema // J. Allergy Clin. Immunol. 2018. Т. 141, № 3. С. 1009–1017.
  18. Bork K. и др. Hereditary angioedema with a mutation in the plasminogen gene // Allergy. 2018. Т. 73, № 2. С. 442–450.

  1. Veronez C.L. и др. Genetic Variation of Kallikrein-Kinin System and Related Genes in Patients With Hereditary Angioedema // Front. Med. 2019. Т. 6, № February. С. 1–6.
  2. Bork K. и др. Guideline: Hereditary angioedema due to C1 inhibitor deficiency: S1 Guideline of the German Society for Angioedema (Deutsche Gesellschaft für Angioödeme, DGA), German Society for Internal Medicine (Deutsche Gesellschaft für Innere Medizin, DGIM), German S // Allergo J. Int. 2019. Т. 28, № 1. С. 16–29.
  3. Alonso M.L.O. и др. Hereditary angioedema: a prospective study of a Brazilian single‐center cohort // Int. J. Dermatol. 2019. С. ijd.14676.
  4. Deroux A. и др. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema // Clin. Exp. Immunol. 2016. Т. 185, № 3. С. 332–337.
  5. F12-related hereditary angioedema with normal C1Inh.
  6. Zuraw B.L. Hereditary angioedema with normal C1 inhibitor: Four types and counting // J. Allergy Clin. Immunol. 2018. Т. 141, № 3. С. 884–885.
  7. Marcelino-Rodriguez I. и др. Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics // Front. Genet. 2019. Т. 10.
  8. Steiner U.C. и др. Hereditary angioedema due to C1 - inhibitor deficiency in Switzerland: clinical characteristics and therapeutic modalities within a cohort study // Orphanet J. Rare Dis. 2016. Т. 11, № 1. С. 43.
  9. Bouillet L. и др. Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients // Ann. Allergy, Asthma Immunol. American College of Allergy, Asthma & Immunology, 2013. Т. 111, № 4. С. 290–294.
  10. Bork K. и др. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. // Am. J. Med. 2006. Т. 119, № 3. С. 267–274.
  11. Bork K., Hardt J., Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency // J. Allergy Clin. Immunol. 2012. Т. 130, № 3. С. 692–697.
  12. Xu Y.-Y. и др. Upper airway edema in 43 patients with hereditary angioedema // Ann. Allergy, Asthma Immunol. 2014. Т. 112, № 6. С. 539-544.e1.
  13. Martinez-Saguer I., Farkas H. Erythema Marginatum as an Early Symptom of Hereditary Angioedema: Case Report of 2 Newborns // Pediatrics. 2016. Т. 137, № 2. С. e20152411.
  14. Zotter Z. и др. The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency. // Orphanet J. Rare Dis. 2014. Т. 9, № 44. С. 1–6.
  15. Hahn J. и др. Angioedema // Dtsch. Aerzteblatt Online. 2017. Т. 114, № 29–30. С. 489–496.
  16. Weldon D. Differential Diagnosis of Angioedema // Immunol. Allergy Clin. North Am. 2006. Т. 26, № 4. С. 603–613.
  17. Farkas H. Management of upper airway edema caused by hereditary angioedema // Allergy, Asthma Clin. Immunol. 2010. Т. 6, № 19. С. 1–8.
  18. Misra L., Khurmi N., Trentman T. Angioedema: Classification, management and emerging therapies for the perioperative physician // Indian J. Anaesth. 2016. Т. 60, № 8. С. 534–541.
  19. Giavina-Bianchi P. и др. Brazilian Guidelines for Hereditary Angioedema Management - 2017 Update Part 1: Definition, Classification and Diagnosis // Clinics. 2018. Т. 73.

  1. Gobert D. и др. Angiœdèmes par déficit acquis en C1-inhibiteur : recommandations du CREAK pour le diagnostic et la prise en charge // La Rev. Médecine Interne. 2020. Т. 41, № 12. С. 838– 842.
  2. Bowen T. и др. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema // Allergy, Asthma Clin. Immunol. 2010. Т. 6, № 24. С. 1–13.
  3. Caballero T. и др. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. // J. Investig. Allergol. Clin. Immunol. 2011. Т. 21, № 5. С. 333–347.
  4. Agostoni A. и др. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond // J. Allergy Clin. Immunol. 2004. Т. 114, № 3. С. S51–S131.
  5. Martinez-Saguer I. и др. Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study // Transfusion. 2014. Т. 54, № 6. С. 1552–1561.
  6. Richards S. и др. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology // Genet. Med. 2015. Т. 17, № 5. С. 405–423.
  7. Farkas H. и др. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency // Allergy Eur. J. Allergy Clin. Immunol. 2017. Т. 72, № 2. С. 300–313.
  8. Aabom A. и др. Clinical characteristics and real-life diagnostic approaches in all Danish children with hereditary angioedema // Orphanet J. Rare Dis. 2017. Т. 12, № 1. С. 55.
  9. Craig T. и др. WAO Guideline for the Management of Hereditary Angioedema // World Allergy Organ. J. 2012. Т. 5, № 12. С. 182–199.
  10. Tarzi M.D. и др. An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema // Clin. Exp. Immunol. 2007. Т. 149, № 3. С. 513–516.
  11. Pedrosa M. и др. Complement Study Versus CINH Gene Testing for the Diagnosis of Type I Hereditary Angioedema in Children // J. Clin. Immunol. 2016. Т. 36, № 1. С. 16–18.
  12. Karim Y. Normal complement C4 values do not exclude hereditary angioedema // J. Clin. Pathol. 2004. Т. 57, № 2. С. 213–214.
  13. Nielsen E. и др. Activation of the Complement, Coagulation, Fibrinolytic and Kallikrein-Kinin Systems During Attacks of Hereditary Angioedema // Scand. J. Immunol. 1996. Т. 44, № 2. С. 185–192.
  14. Zanichelli A. и др. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency // J. Allergy Clin. Immunol. Pract. 2017. Т. 5, № 5. С. 1307–1313.
  15. Riedl M.A. и др. Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data // J. Allergy Clin. Immunol. Pract. Elsevier, 2016. Т. 4, № 5. С. 963–971.
  16. O’Shaughnessy D.F. и др. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant // Br. J. Haematol. 2004. Т. 126, № 1. С. 11–28.
  17. Moreno A.S. и др. Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor // Int. Arch. Allergy Immunol. 2015. Т. 166, № 2. С. 114– 120.

Для продолжения работы требуется вход / регистрация